Delayed
NSE India S.E.
05:29:27 04/06/2024 BST
|
5-day change
|
1st Jan Change
|
170.8
INR
|
-3.18%
|
|
+2.94%
|
-3.49%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,733
|
1,348
|
901.6
|
1,240
|
2,606
|
2,622
|
Enterprise Value (EV)
1 |
3,017
|
2,517
|
2,084
|
2,239
|
3,708
|
3,497
|
P/E ratio
|
9.2
x
|
5.41
x
|
3.74
x
|
5.4
x
|
7.54
x
|
6.27
x
|
Yield
|
1.53%
|
-
|
2.35%
|
-
|
-
|
1.01%
|
Capitalization / Revenue
|
0.41
x
|
0.28
x
|
0.17
x
|
0.26
x
|
0.42
x
|
0.37
x
|
EV / Revenue
|
0.71
x
|
0.52
x
|
0.39
x
|
0.46
x
|
0.6
x
|
0.5
x
|
EV / EBITDA
|
4.95
x
|
3.63
x
|
3.19
x
|
3.91
x
|
4.78
x
|
4.15
x
|
EV / FCF
|
29.4
x
|
47.1
x
|
35.3
x
|
15
x
|
-31
x
|
13.1
x
|
FCF Yield
|
3.4%
|
2.13%
|
2.84%
|
6.66%
|
-3.23%
|
7.61%
|
Price to Book
|
1.21
x
|
0.81
x
|
0.48
x
|
0.58
x
|
1.04
x
|
0.89
x
|
Nbr of stocks (in thousands)
|
35,287
|
35,287
|
35,287
|
35,287
|
35,287
|
35,287
|
Reference price
2 |
49.10
|
38.20
|
25.55
|
35.15
|
73.85
|
74.30
|
Announcement Date
|
25/08/18
|
18/07/19
|
02/09/20
|
03/09/21
|
27/06/22
|
17/07/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
4,271
|
4,797
|
5,293
|
4,836
|
6,132
|
7,017
|
EBITDA
1 |
609.6
|
694.3
|
653.4
|
572.7
|
776.3
|
842.2
|
EBIT
1 |
508.8
|
589.9
|
543.6
|
459.2
|
661.8
|
726.1
|
Operating Margin
|
11.91%
|
12.3%
|
10.27%
|
9.5%
|
10.79%
|
10.35%
|
Earnings before Tax (EBT)
1 |
280.4
|
384.6
|
345.5
|
217.6
|
476.2
|
571.9
|
Net income
1 |
188.4
|
249
|
241.2
|
229.7
|
345.9
|
418.2
|
Net margin
|
4.41%
|
5.19%
|
4.56%
|
4.75%
|
5.64%
|
5.96%
|
EPS
2 |
5.338
|
7.057
|
6.830
|
6.510
|
9.800
|
11.85
|
Free Cash Flow
1 |
102.5
|
53.49
|
59.11
|
149.2
|
-119.8
|
266
|
FCF margin
|
2.4%
|
1.12%
|
1.12%
|
3.09%
|
-1.95%
|
3.79%
|
FCF Conversion (EBITDA)
|
16.82%
|
7.7%
|
9.05%
|
26.05%
|
-
|
31.58%
|
FCF Conversion (Net income)
|
54.42%
|
21.48%
|
24.51%
|
64.95%
|
-
|
63.61%
|
Dividend per Share
2 |
0.7500
|
-
|
0.6000
|
-
|
-
|
0.7500
|
Announcement Date
|
25/08/18
|
18/07/19
|
02/09/20
|
03/09/21
|
27/06/22
|
17/07/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,285
|
1,169
|
1,183
|
999
|
1,102
|
875
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.108
x
|
1.684
x
|
1.81
x
|
1.745
x
|
1.42
x
|
1.039
x
|
Free Cash Flow
1 |
103
|
53.5
|
59.1
|
149
|
-120
|
266
|
ROE (net income / shareholders' equity)
|
14%
|
16%
|
13.6%
|
11.4%
|
14.9%
|
15.3%
|
ROA (Net income/ Total Assets)
|
8.61%
|
9.49%
|
8.01%
|
6.4%
|
8.55%
|
8.73%
|
Assets
1 |
2,187
|
2,625
|
3,011
|
3,590
|
4,045
|
4,789
|
Book Value Per Share
2 |
40.70
|
47.10
|
53.20
|
60.80
|
71.30
|
83.20
|
Cash Flow per Share
2 |
1.720
|
2.010
|
1.730
|
1.150
|
3.610
|
5.750
|
Capex
1 |
197
|
198
|
166
|
105
|
274
|
125
|
Capex / Sales
|
4.6%
|
4.12%
|
3.14%
|
2.16%
|
4.47%
|
1.78%
|
Announcement Date
|
25/08/18
|
18/07/19
|
02/09/20
|
03/09/21
|
27/06/22
|
17/07/23
|
|
1st Jan change
|
Capi.
|
---|
| -3.49% | 74.87M | | +17.43% | 66.51B | | -1.02% | 48.51B | | +20.95% | 43.41B | | +28.14% | 27.76B | | +7.49% | 19.11B | | -4.65% | 16.18B | | +9.34% | 16.58B | | -16.33% | 14.21B | | -28.97% | 14.39B |
Other Specialty Chemicals
|